Cargando…
Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF
Diabetic retinopathy (DR) is one of the more serious complications of diabetes. However, the mechanisms involved in DR are complex and still need to be investigated. The beneficial effects of fisetin have been widely reported, but whether it is beneficial in DR is not clear yet. This study was desig...
Autores principales: | Lai, Meihua, Lan, Caifeng, Zhong, Junmu, Wu, Lijuan, Lin, Chengmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918361/ https://www.ncbi.nlm.nih.gov/pubmed/36777991 http://dx.doi.org/10.1155/2023/7951928 |
Ejemplares similares
-
Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling
por: Long, Lingli, et al.
Publicado: (2019) -
Diabetic Retinopathy and VEGF
por: Gupta, N, et al.
Publicado: (2013) -
The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment
por: Tremolada, Gemma, et al.
Publicado: (2012) -
Inhibition of KCTD10 Affects Diabetic Retinopathy Progression by Reducing VEGF and Affecting Angiogenesis
por: Feng, Yun, et al.
Publicado: (2022) -
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
por: Wang, Tianqin, et al.
Publicado: (2021)